Inequalities in immuno-oncology access across Europe

Bookmark and Share
Published: 14 Dec 2017
Views: 2479
Dr Lydia Makaroff - European Cancer Patient Coalition, Brussels, Belgium

Lydia Makaroff talks to ecancer at EAPM 2017 in Belfast.

She spoke about the importance of innovation in immuno-oncology therapy in cancer.

She underlines the inequalities across Europe to access to these therapies.

This could be due to inefficiencies, lack of cooperation, and lack of healthcare literacy.

She believes patients should be at the centre of care and treatment.